Head to Head Review: CVR Medical (OTCMKTS:CRRVF) and HeartBeam (NASDAQ:BEAT)

CVR Medical (OTCMKTS:CRRVF) and HeartBeam (NASDAQ:BEAT) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, analyst recommendations, valuation and profitability.

Analyst Ratings

This is a summary of current ratings and price targets for CVR Medical and HeartBeam, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVR Medical	0	0	0	0	0.00
HeartBeam	1	2	4	1	2.63

HeartBeam has a consensus price target of $4.83, indicating a potential upside of 427.66%. Given HeartBeam’s stronger consensus rating and higher probable upside, analysts plainly believe HeartBeam is more favorable than CVR Medical.

Profitability

This table compares CVR Medical and HeartBeam’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
CVR Medical	N/A	N/A	N/A
HeartBeam	N/A	-1,034.04%	-434.40%

Insider and Institutional Ownership

7.8% of HeartBeam shares are held by institutional investors. 18.0% of HeartBeam shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares CVR Medical and HeartBeam”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVR Medical	N/A	N/A	N/A	($0.02)	N/A
HeartBeam	N/A	N/A	-$21.01 million	($0.56)	-1.64

HeartBeam is trading at a lower price-to-earnings ratio than CVR Medical, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

CVR Medical has a beta of 32.6, indicating that its stock price is 3,160% more volatile than the S&P 500. Comparatively, HeartBeam has a beta of -0.86, indicating that its stock price is 186% less volatile than the S&P 500.

Summary

HeartBeam beats CVR Medical on 6 of the 10 factors compared between the two stocks.

About CVR Medical

CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.

About HeartBeam

BioTelemetry, Inc., a remote medical technology company, provides remote cardiac monitoring, remote blood glucose monitoring, centralized core laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research customers worldwide. It operates in two segments, Healthcare and Research. The Healthcare segment focuses on the remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders. This segment offers mobile cardiac telemetry services; and event monitoring services, which enable physicians to prescribe wireless event, digital loop event, memory loop event, memory loop event, and non-loop event monitors. It also provides traditional and extended Holter, pacemaker, international normalized ratio, implantable loop recorder, and other implantable cardiac device monitoring services. It serves cardiologists, electrophysiologists, neurologists, and primary care physicians. The Research segment offers laboratory services, such as cardiac monitoring, imaging, scientific consulting, and data management services for drug and medical device trials. Its centralized services comprise electrocardiogram, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, imaging, protocol development, expert reporting, and statistical analysis. It also provides support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The company also focuses on manufacturing, testing, and marketing of cardiac devices and blood glucose monitoring devices, as well as offers contract manufacturing services. BioTelemetry, Inc. was founded in 1994 and is headquartered in Malvern, Pennsylvania.